Fulton Breakefield Broenniman LLC Johnson & Johnson Transaction History

Fulton Breakefield Broenniman LLC

$1.38 Billion
Q4 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 30,845 shares of JNJ stock, worth $4.93 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

30,845

Previous 32,174 4.13%

Holding current value

$4.93 Million

Previous $5.21 Million 14.46%

% of portfolio

0.32%

Previous 0.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$143.34 - $165.86 $190,498 - $220,427	-1,329 Reduced 4.13%	30,845 $4.46 Million
Q3 2024 Oct 16, 2024	SELL	$145.48 - $167.38 $13 Million - $15 Million	-89,356 Reduced 73.53%	32,174 $5.21 Million
Q2 2024 Aug 07, 2024	SELL	$144.38 - $157.78 $788,747 - $861,952	-5,463 Reduced 4.3%	121,530 $17.8 Million
Q1 2024 Apr 29, 2024	SELL	$155.22 - $162.74 $388,515 - $407,338	-2,503 Reduced 1.93%	126,993 $20.1 Million
Q4 2023 Feb 02, 2024	SELL	$145.6 - $158.88 $194,812 - $212,581	-1,338 Reduced 1.02%	129,496 $20.3 Million
Q3 2023 Oct 20, 2023	SELL	$155.75 - $174.48 $93,294 - $104,513	-599 Reduced 0.46%	130,834 $20.4 Million
Q2 2023 Jul 19, 2023	BUY	$154.35 - $166.11 $2.12 Million - $2.28 Million	13,703 Added 11.64%	131,433 $21.8 Million
Q1 2023 Apr 25, 2023	BUY	$151.05 - $180.26 $20,391 - $24,335	135 Added 0.11%	117,730 $18.2 Million
Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $194,002 - $217,725	1,211 Added 1.04%	117,595 $20.8 Million
Q3 2022 Oct 17, 2022	SELL	$161.33 - $179.52 $341,051 - $379,505	-2,114 Reduced 1.78%	116,384 $19 Million
Q2 2022 Jul 28, 2022	SELL	$168.19 - $186.01 $563,268 - $622,947	-3,349 Reduced 2.75%	118,498 $21 Million
Q1 2022 Apr 27, 2022	BUY	$158.14 - $179.59 $97,730 - $110,986	618 Added 0.51%	121,847 $21.6 Million
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $16,372 - $18,166	-105 Reduced 0.09%	121,229 $20.7 Million
Q3 2021 Oct 25, 2021	SELL	$161.5 - $179.47 $72,836 - $80,940	-451 Reduced 0.37%	121,334 $19.6 Million
Q2 2021 Jul 27, 2021	BUY	$159.48 - $171.07 $169,048 - $181,334	1,060 Added 0.88%	121,785 $20.1 Million
Q1 2021 Apr 09, 2021	BUY	$153.07 - $170.48 $2.54 Million - $2.83 Million	16,584 Added 15.92%	120,725 $19.8 Million
Q4 2020 Jan 14, 2021	SELL	$137.11 - $157.38 $2.4 Million - $2.75 Million	-17,503 Reduced 14.39%	104,141 $16.4 Million
Q3 2020 Oct 20, 2020	SELL	$140.38 - $153.83 $71,874 - $78,760	-512 Reduced 0.42%	121,644 $18.1 Million
Q2 2020 Jul 10, 2020	BUY	$128.81 - $155.51 $261,741 - $315,996	2,032 Added 1.69%	122,156 $17.2 Million
Q1 2020 Apr 10, 2020	SELL	$111.14 - $153.99 $293,520 - $406,687	-2,641 Reduced 2.15%	120,124 $15.8 Million
Q4 2019 Jan 14, 2020	BUY	$127.5 - $146.44 $495,720 - $569,358	3,888 Added 3.27%	122,765 $17.9 Million
Q3 2019 Oct 17, 2019	BUY	$126.95 - $142.14 $335,021 - $375,107	2,639 Added 2.27%	118,877 $15.4 Million
Q2 2019 Jul 25, 2019	BUY	$131.15 - $144.24 $140,461 - $154,481	1,071 Added 0.93%	116,238 $16.2 Million
Q1 2019 Apr 17, 2019	BUY	$125.72 - $139.79 $307,259 - $341,646	2,444 Added 2.17%	115,167 $16.1 Million
Q4 2018 Feb 05, 2019	SELL	$122.84 - $147.84 $46,802 - $56,327	-381 Reduced 0.34%	112,723 $14.5 Million
Q3 2018 Oct 24, 2018	SELL	$121.58 - $142.88 $83,160 - $97,729	-684 Reduced 0.6%	113,104 $15.6 Million
Q2 2018 Aug 02, 2018	BUY	$119.4 - $131.76 $2.7 Million - $2.98 Million	22,598 Added 24.78%	113,788 $13.8 Million
Q1 2018 Apr 19, 2018	BUY	$125.1 - $148.14 $177,767 - $210,506	1,421 Added 1.58%	91,190 $11.7 Million
Q4 2017 Jan 30, 2018	SELL	$131.22 - $143.62 $102,351 - $112,023	-780 Reduced 0.86%	89,769 $12.5 Million
Q3 2017 Oct 13, 2017	BUY	$129.47 - $135.38 $11.7 Million - $12.3 Million	90,549	90,549 $11.8 Million

Others Institutions Holding JNJ

# of Institutions

4,506

Shares Held

1.73B

Call Options Held

16.8M

Put Options Held

13.9M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $417B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Johnson & Johnson Transaction History